Skip to main content


Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugs

  • Laia Trigueros-Motos1, 2,
  • Sandra Pérez-Torras1,
  • F Javier Casado1,
  • Míriam Molina-Arcas1, 3 and
  • Marçal Pastor-Anglada1Email author
BMC Cancer201212:434

DOI: 10.1186/1471-2407-12-434

Received: 28 November 2011

Accepted: 19 September 2012

Published: 27 September 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting

Original Submission
28 Nov 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
8 Feb 2012 Reviewed Reviewer Report - Domenico Ribatti
22 Apr 2012 Reviewed Reviewer Report - Hao Xu
27 Jun 2012 Author responded Author comments - Laia Trigueros-Motos
Resubmission - Version 3
27 Jun 2012 Submitted Manuscript version 3
25 Jul 2012 Reviewed Reviewer Report - Hao Xu
Resubmission - Version 4
Submitted Manuscript version 4
19 Sep 2012 Editorially accepted
27 Sep 2012 Article published 10.1186/1471-2407-12-434

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Institut de Biomedicina de la Universitat de Barcelona (IBUB), Universitat de Barcelona, and Centro de Investigación Biomédica en Red – Enfermedades Hepáticas y Digestivas (CIBER EHD)
Centro Nacional de Investigaciones Cardiovasculares (CNIC)
Signal Transduction Laboratory, Cancer Research UK London Research Institute